Publications
April 2025
CJEU revisits Art. 3(a) and 3(c) of the SPC Regulation – Teva BV u.a. vs Merck Sharp & Dohme Corp
Authors:
Dr. Michael Best, Dr. Oliver Ladendorf,
Dr. Jonas Thelemann
January 2021
Practical consequences of the new Rules of Procedure of the Boards of Appeal
Authors:
Dr. Evy Corbanie, Dr. Stefan Weist,
Dr. Marc Gerauer
October 2020
Patent Infringement in 3D Printing
Technology and Liability of the Managing Director
Author:
Dr. Marc Gerauer
July 2018
Patentverletzung im Hinblick auf den 3D-Druck und Geschäftsführerhaftung
Author:
Dr. Marc Gerauer
June 2018
May 2017
Patentability of products obtained by essentially biological processes in Europe
Authors:
Dr. Oliver Ladendorf, Dr. Evy Corbanie
April 2016
What is the relevant date of marketing authorization to determine the term of an SPC?
Authors:
Dr. Oliver Ladendorf, Dr. Alexander Kleefen
April 2016
May a part of a fusion protein be considered an "active ingredient"? Yes, says the ECJ in Forsgre
Authors:
Dr. Oliver Ladendorf, Dr. Alexander Kleefen
March 2016
Eli Lilly vs. HGS (C-493/12):
The UK High Court clarifies the ECJ's enigmatic decision
Authors:
Dr. Oliver Ladendorf, Dr. Alexander Kleefen
Contact
KRAUS & LEDERER PartGmbB
Patentanwälte | European Patent and Trademark Attorneys
Thomas-Wimmer-Ring 15
80539 Munich
Germany
T +49 89 29060 - 0
F +49 89 29060 - 111
www.kraus-lederer.de
Proud to be honoured
We have received awards from renowned national and international handbooks, magazines, newspapers and international professional journals and are proud when good work is recognized.
News
G 1/25: Adapting the Description at the EPO — What the Decision Means in Practice
EPO Enlarged Board of Appeal, decision of 3 September 2026 …
Juve Patent recommends KRAUS & LEDERER
We are delighted to have been recommended in the current Patent Germany Ranking 2025 …